Back
08 October

FDA Renews M-CERSI Grant to School of Pharmacy

Published 10/5/18 on UMB News The University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) has been renewed for funding under a cooperative agreement grant from the U.S. Food and Drug Administration (FDA). A collaborative partnership led by James Polli, …

02 October

Virtually Onstage

Published 10/1/18 in TERP magazine UMD Artists, Researchers Open New Views of Opera BY CHRIS CARROLL | ILLUSTRATION BY JASON KEISLING For decades, audiences have watched from their seats as a group of nuns are marched to the guillotine at the climax of …

02 October

Recipes for Disaster in Street Drugs

Published 10/2/18 in Maryland Today Drug Users, Hospitals Struggle Amid Increasingly Complex Blends, Research Finds Since the start of his drug research career in the 1970s, Eric Wish, director of UMD’s Center for Substance Abuse Research (CESAR), has gotten used …

02 October

Wave of complex street drugs complicates diagnosis of overdose

Published 10/1/18 in MultiBriefs Drug overdoses are increasingly common and more lethal in nearly every area of the country. New research provides a snapshot of regional illegal drug use. The report also highlights the complexity of detecting and treating severe drug-related events …

05 September

ImmuCision BioTherapeutics Receives Quick Financial Backing, Locates in University of Maryland BioPark

Published 9/5/18 on PR Newswire BALTIMORE, Sept. 5, 2018 /PRNewswire/ — The University of Maryland (UM) BioPark and UM Ventures announced today that ImmuCision BioTherapeutics (ICBT), a UM, Baltimore startup company specializing in immunotherapy, has established offices and laboratory space in the BioPark. ICBT, which commercializes and develops dendritic cell …